NEW YORK (TheStreet) -- RATINGS CHANGES
AES (AES) was upgraded at J.P. Morgan to overweight. Company has multiple potential catalysts and the stock could be at an inflection point, J.P. Morgan said.
Biomarin (BMRN) was initiated with an overweight rating at Barclays. Twelve-month price target is $150. Company has strong operating momentum with major pipeline opportunities, Barclays said.
Dreamworks (DWA) was upgraded at Stifel to buy from hold. Twelve-month price target is $34. Company is shifting its movies toward a younger viewer, Stifel said.
Under Armour (UA) was upgraded at DA Davidson to buy from neutral. Twelve-month price target is $91. Stock has pulled back 10%, but the company has multiple potential catalysts for the second half of the year, DA Davidson said.
Virtus Investment Partners (VRTS) was upgraded at Jefferies to buy from hold. Unchanged $145 price target. Current valuation appears attractive even under the assumption of total loss of AlphaSector AUM and a negative outcome from the SEC investigation, Jefferies said. A positive outcome for either should provide significant upside optionality, Jefferies also said.
Get more analyst stock comments and changes to price targets and earnings estimates daily in TheStreet's Real Money. Read them here.